Literature DB >> 26261615

Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.

Naohiro Makise1, Teppei Morikawa1, Taketo Kawai2, Tohru Nakagawa2, Haruki Kume2, Yukio Homma2, Masashi Fukayama1.   

Abstract

Squamous differentiation is the most common histological variation in urothelial carcinoma (UC). However, the clinical significance of squamous differentiation in upper urinary tract UC is unclear. To investigate the significance of squamous differentiation, hematoxylin and eosin stained slides from 140 patients with upper urinary tract UC who underwent nephroureterectomy were reviewed by a single pathologist and the presence of squamous differentiation was recorded. Squamous differentiation was observed in 23 out of 140 studied cases (16%). Squamous differentiation significantly correlated with several adverse prognostic factors including histological grade 3 tumors, presence of lymphovascular invasion, concomitant carcinoma in situ, advanced tumor stage, and occurrence of lymph node metastasis. The Kaplan-Meier and univariate Cox regression analyses revealed that the presence of squamous differentiation was significantly associated with shorter metastasis-free survival [log-rank P = 0.030; univariate hazard ratio (HR), 2.30; 95% confidence interval (CI), 1.06-4.99], cancer-specific survival (log-rank P = 0.0024; univariate HR 3.34; 95% CI, 1.47-7.85), and overall survival (log-rank P = 0.018; univariate HR 2.39; 95% CI, 1.13-5.06) after nephroureterectomy. However, in multivariate analyses, squamous differentiation was not significantly associated with patient outcomes. These findings suggest that squamous differentiation is associated with disease progression, but is not an independent predictor of a worse prognosis in patients with upper urinary tract UC.

Entities:  

Keywords:  Cancer; histology; pathology; prognostic marker; renal pelvis; ureter

Mesh:

Year:  2015        PMID: 26261615      PMCID: PMC4525949     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  Publication bias in clinical research.

Authors:  P J Easterbrook; J A Berlin; R Gopalan; D R Matthews
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

2.  Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy.

Authors:  L Mazzucchelli; M Bacchi; U E Studer; R Markwalder; R W Sonntag; R Kraft
Journal:  Int J Cancer       Date:  1994-04-01       Impact factor: 7.396

3.  Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: a mapping study.

Authors:  Wojciech Jozwicki; Jan Domaniewski; Zdzislaw Skok; Zbigniew Wolski; Ewa Domanowska; Grazyna Jozwicka
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

4.  Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.

Authors:  Bas W G van Rhijn; Mireia Musquera; Liyang Liu; André N Vis; Tahlita C M Zuiverloon; Geert J L H van Leenders; Wim J Kirkels; Ellen C Zwarthoff; Egbert R Boevé; Adriaan C Jöbsis; Bharati Bapat; Michael A S Jewett; Alexandre R Zlotta; Theo H van der Kwast
Journal:  Mod Pathol       Date:  2014-11-28       Impact factor: 7.842

Review 5.  Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.

Authors:  Ichiya Honma; Naoya Masumori; Eiji Sato; Akio Takayanagi; Atsushi Takahashi; Naoki Itoh; Mitsuharu Tamagawa; Masa-aki Sato; Taiji Tsukamoto
Journal:  Urology       Date:  2004-10       Impact factor: 2.649

6.  Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan.

Authors:  Muh Hwa Yang; Chueh Chuan Yen; Po Min Chen; Wei Shu Wang; Yen Hwa Chang; William Ji-Shien Huang; Frank S Fan; Tzeon Jye Chiou; Jin Hwang Liu; Kuang Kuo Chen
Journal:  Urology       Date:  2002-02       Impact factor: 2.649

7.  High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.

Authors:  Delia Perez-Montiel; Paul E Wakely; Ondrej Hes; Michal Michal; Saul Suster
Journal:  Mod Pathol       Date:  2006-04       Impact factor: 7.842

8.  The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.

Authors:  Alberto A Antunes; Luciano J Nesrallah; Marcos F Dall'Oglio; Carlos E Maluf; Cesar Camara; Katia R Leite; Miguel Srougi
Journal:  Int Braz J Urol       Date:  2007 May-Jun       Impact factor: 1.541

9.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

10.  The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.

Authors:  H A Frazier; J E Robertson; R K Dodge; D F Paulson
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

View more
  3 in total

1.  Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma.

Authors:  Jianpeng Yu; Gang Li; Aixiang Wang; Qiang Luo; Zihao Liu; Yuanjie Niu; Yanhui Mei
Journal:  Ann Transl Med       Date:  2019-08

2.  Rapid recurrence of squamous cell carcinoma at a lymphocele after nephroureterectomy: A rare case report.

Authors:  Kosuke Ogawa; Yousuke Shimizu; Shoko Uketa; Noriaki Utsunomiya; Satsuki Asai; Misa Ishihara; Kimio Hashimoto; Sojun Kanamaru
Journal:  IJU Case Rep       Date:  2021-02-15

Review 3.  Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Gopal Sharma; Anuj Kumar Yadav; Tarun Pareek; Pawan Kaundal; Shantanu Tyagi; Sudheer Kumar Devana; Shrawan Kumar Singh
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.